Loading clinical trials...
Loading clinical trials...
To assess the plasma pharmacokinetics, the routes extent of elimination, and the metabolites of TS-142 after single oral dose of \[14C\] TS-142 in Japanese healthy male subjects. To assess the safety...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Taisho Pharmaceutical Co., Ltd.
NCT07367958 · Healthy Male Subjects
NCT05245669 · Healthy Male Subjects
NCT03931590 · Healthy Male Subjects
NCT06472531 · Healthy Male Subjects, Suspected Prostate Cancer
NCT06111196 · Healthy Male Subjects
Taisho Pharmaceutical Co., Ltd selected site
Tokyo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions